Age-based (<65 vs ≥65 years) incidence of infections and serious infections with tofacitinib versus biological DMARDs in rheumatoid arthritis clinical trials and the US Corrona RA registry

Detalles Bibliográficos
Autores principales: Winthrop, Kevin L, Citera, Gustavo, Gold, David, Henrohn, Dan, Connell, Carol A, Shapiro, Andrea B, Shi, Harry, Onofrei, Alina M, Pappas, Dimitrios A, Schulze-Koops, Hendrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788057/
https://www.ncbi.nlm.nih.gov/pubmed/33046447
http://dx.doi.org/10.1136/annrheumdis-2020-218992

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788057/
https://www.ncbi.nlm.nih.gov/pubmed/33046447
http://dx.doi.org/10.1136/annrheumdis-2020-218992

Ejemplares similares